PO Q2 2021 - Cover1

Volume 22 Issue 2 | April/May/June 2021
TM
SHOW ISSUE
BIO Digital
DIA 2021 Global
Annual Meeting - Virtual
DCAT Week 2021 - Virtual
CPhI North America
SUPPLY CHAIN
Building Outsourcing
Strategies That Reduce
Risk and Promote Flexible,
Patient-Centric and
Cost-Effective Supply Chains
CLINICAL TRIALS
Data Capture in the Age
of Decentralized Trials:
Why " Electronic " Is Not Enough
CONTRACT MANUFACTURING
Specialty Pharmacy Benefit
Management Mitigates High
Cost of Gene Therapies for
Rare and Orphan Diseases
www.pharmoutsourcing.com
http://www.pharmoutsourcing.com

PO Q2 2021

Table of Contents for the Digital Edition of PO Q2 2021

EDITOR'S MESSAGE
EDITORIAL ADVISORY BOARD
CN PERSPECTIVES
SOCIAL MEDIA CONNECTIONS
INSIDER INSIGHT: Sparking Continued Interest in Science, Post-Pandemic, Requires Raising the Next Generation of Life Sciences Talent
CONTRACT MANUFACTURING: Strengthening Biopharma’s Resilience
CONTRACT RESEARCH: Utilization of Physiologically Based Pharmacokinetics Modeling in the Development of Orally Administered Formulations Intended for Systemic Delivery of Small Molecules
CONTRACT MANUFACTURING: Maximizing Cloud Value in Life Sciences
SUPPLY CHAIN: Transforming to Decentralized Trials
SUPPLY CHAIN: Adding State Licensing to Your Cell and Gene Launch Strategy
SUPPLY CHAIN: Building Outsourcing Strategies That Reduce Risk and Promote Flexible, Patient-Centric and Cost-Effective Supply Chains
ROUNDTABLE: Up for Debate. Interchangeable Data/Document Management: The Key to Transforming Life Sciences Experiences?
CLINICAL TRIALS: Data Capture in the Age of Decentralized Trials: Why “Electronic” Data Capture in the Age of Decentralized Trials: Why “Electronic” Is Not Enough
CLINICAL TRIALS: Outsourcing Clinical Research Support – Time to Put Safety First
CONTRACT MANUFACTURING: Specialty Pharmacy Benefit Management Mitigates High Cost of Gene Therapies for Rare and Orphan Diseases
CLINICAL TRIALS: How Real World Data, Decentralized Trials, and Diversity Will Put the Patient First
CLINICAL TRIALS: Achieving Clinical Trial Diversity Through Actionable Steps
SUPPLY CHAIN: Light at the End of the Tunnel: Serialization of Pharmaceutical Products Nearly Complete
HORIZON LINES
INDUSTRY NEWS
ADVERTISER’S INDEX
PO Q2 2021 - Cover1
PO Q2 2021 - Cover2
PO Q2 2021 - 1
PO Q2 2021 - EDITOR'S MESSAGE
PO Q2 2021 - 3
PO Q2 2021 - 4
PO Q2 2021 - 5
PO Q2 2021 - EDITORIAL ADVISORY BOARD
PO Q2 2021 - 7
PO Q2 2021 - CN PERSPECTIVES
PO Q2 2021 - SOCIAL MEDIA CONNECTIONS
PO Q2 2021 - INSIDER INSIGHT: Sparking Continued Interest in Science, Post-Pandemic, Requires Raising the Next Generation of Life Sciences Talent
PO Q2 2021 - 11
PO Q2 2021 - CONTRACT MANUFACTURING: Strengthening Biopharma’s Resilience
PO Q2 2021 - 13
PO Q2 2021 - 14
PO Q2 2021 - 15
PO Q2 2021 - CONTRACT RESEARCH: Utilization of Physiologically Based Pharmacokinetics Modeling in the Development of Orally Administered Formulations Intended for Systemic Delivery of Small Molecules
PO Q2 2021 - 17
PO Q2 2021 - 18
PO Q2 2021 - 19
PO Q2 2021 - CONTRACT MANUFACTURING: Maximizing Cloud Value in Life Sciences
PO Q2 2021 - 21
PO Q2 2021 - 22
PO Q2 2021 - 23
PO Q2 2021 - SUPPLY CHAIN: Transforming to Decentralized Trials
PO Q2 2021 - 25
PO Q2 2021 - 26
PO Q2 2021 - 27
PO Q2 2021 - SUPPLY CHAIN: Adding State Licensing to Your Cell and Gene Launch Strategy
PO Q2 2021 - 29
PO Q2 2021 - SUPPLY CHAIN: Building Outsourcing Strategies That Reduce Risk and Promote Flexible, Patient-Centric and Cost-Effective Supply Chains
PO Q2 2021 - 31
PO Q2 2021 - ROUNDTABLE: Up for Debate. Interchangeable Data/Document Management: The Key to Transforming Life Sciences Experiences?
PO Q2 2021 - 33
PO Q2 2021 - 34
PO Q2 2021 - 35
PO Q2 2021 - CLINICAL TRIALS: Data Capture in the Age of Decentralized Trials: Why “Electronic” Data Capture in the Age of Decentralized Trials: Why “Electronic” Is Not Enough
PO Q2 2021 - 37
PO Q2 2021 - 38
PO Q2 2021 - 39
PO Q2 2021 - CLINICAL TRIALS: Outsourcing Clinical Research Support – Time to Put Safety First
PO Q2 2021 - 41
PO Q2 2021 - CONTRACT MANUFACTURING: Specialty Pharmacy Benefit Management Mitigates High Cost of Gene Therapies for Rare and Orphan Diseases
PO Q2 2021 - 43
PO Q2 2021 - 44
PO Q2 2021 - 45
PO Q2 2021 - CLINICAL TRIALS: How Real World Data, Decentralized Trials, and Diversity Will Put the Patient First
PO Q2 2021 - 47
PO Q2 2021 - 48
PO Q2 2021 - 49
PO Q2 2021 - CLINICAL TRIALS: Achieving Clinical Trial Diversity Through Actionable Steps
PO Q2 2021 - 51
PO Q2 2021 - 52
PO Q2 2021 - SUPPLY CHAIN: Light at the End of the Tunnel: Serialization of Pharmaceutical Products Nearly Complete
PO Q2 2021 - 54
PO Q2 2021 - 55
PO Q2 2021 - HORIZON LINES
PO Q2 2021 - 57
PO Q2 2021 - 58
PO Q2 2021 - INDUSTRY NEWS
PO Q2 2021 - 60
PO Q2 2021 - 61
PO Q2 2021 - 62
PO Q2 2021 - 63
PO Q2 2021 - ADVERTISER’S INDEX
PO Q2 2021 - Cover3
PO Q2 2021 - Cover4
https://www.nxtbook.com/comparenetworks/PharmaceuticalOutsourcing/po-q2-2021
https://www.nxtbook.com/comparenetworks/PharmaceuticalOutsourcing/PharmaceuticalOutsourcing2021CompanyFocus
https://www.nxtbook.com/comparenetworks/PharmaceuticalOutsourcing/PharmaceuticalOutsourcingQ42020
https://www.nxtbookmedia.com